ESR1 and prostate carcinoma: There was highly significant enrichment of ESR1 binding sites within genomic regions associated with breast cancer, height, MS and prostate cancer, which was consistent over multiple datasets and increased in magnitude for binding sites shared between multiple datasets (Additional file 1: Table S5, Table 1).